Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects
PROTEOMICS · 2024
DOI: 10.1002/pmic.202300114 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PROTEOMICS, 2024. Verfasst von Megan Bonsor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroproteomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany. Hauptthemen laut MEDLINE: Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Huntington's Disease Society of America, Berman-Topper Family HD Career Development Fellowship, CHDI Foundation.
Abstract (Originalsprache)
Currently, nine polyglutamine (polyQ) expansion diseases are known. They include spinocerebellar ataxias (SCA1, 2, 3, 6, 7, 17), spinal and bulbar muscular atrophy (SBMA), dentatorubral‐pallidoluysian atrophy (DRPLA), and Huntington's disease (HD). At the root of these neurodegenerative diseases are trinucleotide repeat mutations in coding regions of different genes, which lead to the production of proteins with elongated polyQ tracts. While the causative proteins differ in structure and molecular mass, the expanded polyQ domains drive pathogenesis in all these diseases. PolyQ tracts mediate the association of proteins leading to the formation of protein complexes involved in gene expression regulation, RNA processing, membrane trafficking, and signal transduction. In this review, we discuss commonalities and differences among the nine polyQ proteins focusing on their structure and function as well as the pathological features of the respective diseases. We present insights from AlphaFold‐predicted structural models and discuss the biological roles of polyQ‐containing proteins. Lastly, we explore reported protein–protein interaction networks to highlight shared protein interactions and their potential relevance in disease development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroproteomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
ORCID-Profile: Erich E Wanker, Eduardo Silva Ramos
Förderung
- Huntington's Disease Society of America
- Berman-Topper Family HD Career Development Fellowship
- CHDI Foundation
Zitieren
APA
Bonsor, M., Ammar, O., Schnoegl, S., Wanker, E. E., & Silva Ramos, E. (2024). Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects. PROTEOMICS. https://doi.org/10.1002/pmic.202300114
Vancouver
Bonsor M, Ammar O, Schnoegl S, Wanker EE, Silva Ramos E. Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects. PROTEOMICS. 2024. doi:10.1002/pmic.202300114
BibTeX
@article{Bonsor2024,
author = {Bonsor, Megan and Ammar, Orchid and Schnoegl, Sigrid and Wanker, Erich E and Silva Ramos, Eduardo},
title = {Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects},
journal = {PROTEOMICS},
year = {2024},
doi = {10.1002/pmic.202300114}
}
EUVIMED